Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 78

New brain imaging technique can detect early frontotemporal dementia

A new international study led by researchers at Karolinska Institutet demonstrates that it is possible to detect subtle changes in the brain and identify early signs of hereditary frontotemporal dementia using advanced brain imaging techniques. The study is published in Molecular Psychiatry.

Frontotemporal dementia, or FTD, is a neurodegenerative disease that often affects people in middle age and is a common cause of dementia before the age of 65. The disease is particularly difficult to diagnose in its early stages, as the earliest symptoms are behavioral changes and may resemble primary psychiatric disease and symptoms later on can resemble conditions such as Alzheimer’s disease and Parkinson’s disease. In about a third of cases, is hereditary, making families with known mutations an important resource for research.

Toxic Salton Sea dust triggers changes in lung microbiome after just one week

Dust from California’s drying Salton Sea doesn’t just smell bad. Scientists from UC Riverside found that breathing the dust can quickly re-shape the microscopic world inside the lungs.

Genetic or have previously been shown to have an effect on lung microbes. However, this discovery marks the first time scientists have observed such changes from environmental exposure rather than a disease.

Published in the journal mSphere, the study shows that inhalation of airborne dust collected close to the shallow, landlocked lake alters both the microbial landscape and immune responses in mice that were otherwise healthy.

Ectopic expression of a mechanosensitive channel confers spatiotemporal resolution to ultrasound stimulations of neurons for visual restoration

Cadoni et al. show that expression of the bacterial sonogenetic ion channel MscL(G22S) allows focused ultrasound (FUS) neuromodulation of the mouse visual cortex. They even provide evidence for possible induction of a visual percept in mice via this approach, though much more work is needed to make this into a useful visual restoration method. It should be noted that some of the FUS frequencies used in Cadoni et al.’s experiments were quite high (15 MHz), so a surgically implanted cranial window was needed. I personally think that it would be better to focus on frequencies that can be employed in a transcranial fashion to minimize invasiveness. That said, there is still merit to moderately invasive methods as seen here. #sonogenetics [ https://www.nature.com/articles/s41565-023-01359-6](https://www.nature.com/articles/s41565-023-01359-6)

Sonogenetics provides neuron-specific activation at high spatiotemporal resolution ex vivo in retina and in vivo deep in the visual cortex using the AAV gene delivery of a mechanosensitive ion channel and low-intensity ultrasound stimulations.

Optical device distinguishes blood flow signals from the brain and scalp

Measuring blood flow in the brain is critical for responding to a range of neurological problems, including stroke, traumatic brain injury (TBI) and vascular dementia. But existing techniques, including magnetic resonance imaging and computed tomography, are expensive and therefore not widely available.

Researchers from the USC Neurorestoration Center and the California Institute of Technology (Caltech) have built a simple, noninvasive alternative. The device takes a technique currently used in animal studies known as speckle contrast (SCOS) and adapts it for potential clinical use in humans. It works by capturing images of scattered with an affordable, high-resolution camera.

“It’s really that simple. Tiny blood cells pass through a laser beam, and the way the light scatters allows us to measure and volume in the brain,” said Charles Liu, MD, Ph.D., professor of clinical neurological surgery, urology and surgery at the Keck School of Medicine of USC, director of the USC Neurorestoration Center and co-senior author of the new research.

Decoding the T cell burst: Signature genes predict T cell expansion in cancer immunotherapy

The ability of immune cells—particularly CD8+ T cells—to launch a rapid burst of proliferation inside tumors is key to the success of modern day cancer immunotherapies. However, the factors and mechanisms that drive this burst in proliferation remain poorly understood, making it difficult to predict which patients will benefit from treatment. A deeper understanding of this T cell burst could also guide the development of new therapies that enhance T cell proliferation and improve treatment outcomes.

To tackle this challenge, an international team of researchers led by Associate Professor Satoshi Ueha and Professor Kouji Matsushima from the Research Institute for Biomedical Sciences, Tokyo University of Science (TUS), Japan, developed a novel approach to monitor CD8⁺ T cell activity over time. Their findings, published in the journal Nature Communications on October 20, 2025, sheds new light on how T cells expand in the tumor—and how their expansion can be predicted, and ultimately, therapeutically reactivated.

“The development of immunotherapies has been hindered by our inability to comprehensively monitor their effects on —particularly cancer-fighting T cells—over time,” explains Dr. Ueha. “Building on our previous work, we developed a method to track these cells longitudinally in the tumor, allowing us to gain deeper insights into the burst of that drives effective anti-tumor responses.”

Macrophages can fuel liver cancer spread by supplying acetate to tumor cells

Chinese researchers have revealed a mechanism that triggers metastasis of hepatocellular carcinoma (HCC)—the most common type of primary liver cancer—through the production of acetate by tumor-associated macrophages.

Acetate is important to cancer metastasis because it promotes the synthesis of acetyl-coenzyme A (acetyl-CoA), which is a pivotal metabolic intermediate in the catabolism of glucose, lipids, and , as well as the biosynthesis of lipids and the TCA cycle. Acetyl-CoA also functions as a signaling molecule due to its role in lysine acetylation. Increased acetyl-CoA production is characteristic of metastatic cancers.

Researchers have known that acetate levels in the blood are significantly lower than in cancer tissues, suggesting the presence of acetate-producing cells within the cancer microenvironment. However, the exact source of acetate in the cancer microenvironment was previously unclear.

What the Next Pandemic Will Look Like (And Where It Will Start)

Doctors say another pandemic could arrive sooner than most people think. In this new video, you’ll find out why the risk is rising, the simple signs that tell experts a real outbreak has begun, and when that official Day One would likely be called.

🔔 Don’t forget to SUBSCRIBE! 🔔

SUGGEST A TOPIC:
https://bit.ly/suggest-an-infographic… Come chat with me: / discord 🔖 MY SOCIAL PAGES TikTok ► / theinfographicsshow Facebook ► / theinfographicsshow 📝 SOURCES: https://freepaste.link/vhx93r0mwj All videos are based on publicly available information unless otherwise noted.

💬 Come chat with me: / discord.

🔖 MY SOCIAL PAGES
TikTok ► / theinfographicsshow.
Facebook ► / theinfographicsshow.

📝 SOURCES:

Continue reading “What the Next Pandemic Will Look Like (And Where It Will Start)” | >

Gene deficiency that causes obesity also protects from heart disease, finds new study

Deficiency of the gene melanocortin 4 receptor (MC4R) is linked with obesity among adults. A recent study has found that the same deficiency also leads to surprising outcomes such as reduced risk of heart disease, lower cholesterol, and triglycerides. These results contradict the well-established correlation between obesity and cardiovascular diseases.

The researchers scanned the of 7,719 children from the Genetics of Obesity Study (GOOS) cohort. They identified 316 probands—first person in a family to draw medical attention to a —and 144 adult family members with obesity due to loss-of-function (LoF) MC4R mutations.

Even after adjusting for weight, these individuals showed better blood pressure profiles and when compared to 336,728 controls from the UK Biobank.

Deciphering Breast Cancer: Spatial and Molecular Insights into Tumor Evolution

In recognition of Breast Cancer Awareness Month, join us for a live webinar to uncover the complexity of tumor biology and the surprising resilience of normal tissue. This event will feature two expert-led presentations: one demonstrating how protein multiplexing and quantitative imaging uncover the hidden heterogeneity of breast tumors, and another examining how natural tissue remodeling can both suppress and influence oncogenic transformation. A live discussion and Q&A session will follow, giving you the opportunity to engage directly with leading researchers and gain valuable insights to improve cancer diagnosis, guide therapy decisions, and inform prevention strategies. All sessions will be available on demand, allowing flexible access for continued learning and engagement.

Featured Talks:

/* */